Our results indicated that CD8+ T cells in healthy adults might have immunological memory capacity to OCT4 and Sox2 (Fig 3A), suggesting that CD8+ CIK cells may kill ovarian cancer cells via binding OCT4 and Sox2 antigens. The gene discussed is CD8A; the disease is ovarian carcinoma.